133 related articles for article (PubMed ID: 37707410)
1. Prediction of MYCN Gene Amplification in Pediatric Neuroblastomas: Development of a Deep Learning-Based Tool for Automatic Tumor Segmentation and Comparative Analysis of Computed Tomography-Based Radiomics Features Harmonization.
Yeow LY; Teh YX; Lu X; Srinivasa AC; Tan E; Tan TSE; Tang PH; Kn BP
J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):786-795. PubMed ID: 37707410
[TBL] [Abstract][Full Text] [Related]
2. CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma.
Tan E; Merchant K; Kn BP; Cs A; Zhao JJ; Saffari SE; Tan PH; Tang PH
Childs Nerv Syst; 2022 Aug; 38(8):1487-1495. PubMed ID: 35460355
[TBL] [Abstract][Full Text] [Related]
3. Role of MRI radiomics for the prediction of MYCN amplification in neuroblastomas.
Ghosh A; Yekeler E; Teixeira SR; Dalal D; States L
Eur Radiol; 2023 Oct; 33(10):6726-6735. PubMed ID: 37178203
[TBL] [Abstract][Full Text] [Related]
4. Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study.
Di Giannatale A; Di Paolo PL; Curione D; Lenkowicz J; Napolitano A; Secinaro A; Tomà P; Locatelli F; Castellano A; Boldrini L
Pediatr Blood Cancer; 2021 Sep; 68(9):e29110. PubMed ID: 34003574
[TBL] [Abstract][Full Text] [Related]
5. Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification.
Wu H; Wu C; Zheng H; Wang L; Guan W; Duan S; Wang D
Eur Radiol; 2021 May; 31(5):3080-3089. PubMed ID: 33118047
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
7. Role of Textural Analysis of Pretreatment
Mishra A; Ravina M; Kote R; Kumar A; Kashyap Y; Dasgupta S; Reddy M
Indian J Nucl Med; 2023; 38(3):255-263. PubMed ID: 38046976
[TBL] [Abstract][Full Text] [Related]
8. Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancers.
Masson I; Da-Ano R; Lucia F; Doré M; Castelli J; Goislard de Monsabert C; Ramée JF; Sellami S; Visvikis D; Hatt M; Schick U
Med Phys; 2021 Jul; 48(7):4099-4109. PubMed ID: 34008178
[TBL] [Abstract][Full Text] [Related]
9. A Random Forest-based Classifier for MYCN Status Prediction in Neuroblastoma using CT Images.
Pereira T; Silva F; Claro P; Carvalho DC; Dias SC; Torrao H; Oliveira HP
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():3854-3857. PubMed ID: 36086471
[TBL] [Abstract][Full Text] [Related]
10. CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma.
Chen X; Wang H; Huang K; Liu H; Ding H; Zhang L; Zhang T; Yu W; He L
Front Oncol; 2021; 11():687884. PubMed ID: 34109133
[TBL] [Abstract][Full Text] [Related]
11. Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN-amplification in neuroblastomas: preliminary results.
Ghosh A; Yekeler E; Dalal D; Holroyd A; States L
Eur Radiol; 2022 Dec; 32(12):8453-8462. PubMed ID: 35437614
[TBL] [Abstract][Full Text] [Related]
12. Predicting amplification of
Giwa A; Rossouw SC; Fatai A; Gamieldien J; Christoffels A; Bendou H
Future Oncol; 2021 Dec; 17(34):4769-4783. PubMed ID: 34751044
[TBL] [Abstract][Full Text] [Related]
13. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
[TBL] [Abstract][Full Text] [Related]
14. MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients.
Chang HH; Tseng YF; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Jeng YM
Mod Pathol; 2020 Apr; 33(4):531-540. PubMed ID: 31695155
[TBL] [Abstract][Full Text] [Related]
15. Can texture analysis based on single unenhanced CT accurately predict the WHO/ISUP grading of localized clear cell renal cell carcinoma?
Wang X; Song G; Jiang H; Zheng L; Pang P; Xu J
Abdom Radiol (NY); 2021 Sep; 46(9):4289-4300. PubMed ID: 33909090
[TBL] [Abstract][Full Text] [Related]
16. Imaging biomarkers to stratify lymph node metastases in abdominal CT - Is radiomics superior to dual-energy material decomposition?
Mahmoudi S; Koch V; Santos DPD; Ackermann J; Grünewald LD; Weitkamp I; Yel I; Martin SS; Albrecht MH; Scholtz JE; Vogl TJ; Bernatz S
Eur J Radiol Open; 2023; 10():100459. PubMed ID: 36561422
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
18. ComBat Harmonization for MRI Radiomics: Impact on Nonbinary Tissue Classification by Machine Learning.
Leithner D; Nevin RB; Gibbs P; Weber M; Otazo R; Vargas HA; Mayerhoefer ME
Invest Radiol; 2023 Sep; 58(9):697-701. PubMed ID: 36897814
[TBL] [Abstract][Full Text] [Related]
19. Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Campbell K; Naranjo A; Hibbitts E; Gastier-Foster JM; Bagatell R; Irwin MS; Shimada H; Hogarty M; Park JR; DuBois SG
Eur J Cancer; 2020 Jul; 133():112-119. PubMed ID: 32492633
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of virtual monoenergetic images from kilovoltage peak images using wavelet loss enhanced CycleGAN for improving radiomics features reproducibility.
Xu Z; Li M; Li B; Shu H
Quant Imaging Med Surg; 2024 Mar; 14(3):2370-2390. PubMed ID: 38545083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]